US Stock MarketDetailed Quotes
ABSI Absci Corp
- 2.560
- +0.010+0.39%
Close Nov 22 16:00 ET
- 2.650
- +0.090+3.52%
Post 20:01 ET
294.03MMarket Cap-2752P/E (TTM)
2.640High2.520Low1.09MVolume2.580Open2.550Pre Close2.81MTurnover1.27%Turnover RatioLossP/E (Static)114.86MShares6.72052wk High1.46P/B220.84MFloat Cap1.35052wk Low--Dividend TTM86.26MShs Float31.530Historical High--Div YieldTTM4.71%Amplitude1.111Historical Low2.569Avg Price1Lot Size
About Absci Corp Company
Absci Corp. is the drug and target discovery company harnessing deep learning AI and synthetic biology to expand the therapeutic potential of proteins. It partners with pharma and biotech innovators to create the next generation of protein-based drugs. The company was founded by Sean McClain in 2011 and is headquartered in Vancouver, WA.
Company Profile
SymbolABSI
Company NameAbsci Corp
Listing DateJul 22, 2021
Issue Price16.00
Founded2011
CEOMr. Sean McClain
MarketNASDAQ
Employees156
Fiscal Year Ends12-31
Address18105 SE Mill Plain Boulevard
CityVancouver
ProvinceWashington
CountryUnited States of America
Zip Code98683
Phone1-360-949-1041
Websitehttp://www.absci.com
Company Executives
- Name
- Position
- Salary
- Sean McClain
- Chief Executive Officer and Director
- 4.01M
- Todd Bedrick
- Chief Accounting Officer
- --
- Dr. Andreas Busch, PhD
- Chief Innovation Officer
- 4.73M
- Dr. Zachariah Jonasson, PhD
- Chief Financial Officer and Chief Business Officer
- 155.12K
- Dr. Ivana Magovcevic-Liebisch, J.D.,PhD
- Chairman of the Board
- 203.34K
- Frans Van Houten
- Director
- --
- Daniel A. Rabinovitsj
- Independent Director
- 119.00K
- Amrit Nagpal
- Independent Director
- 106.82K
- Professor Menelas Pangalos, PhD
- Independent Director
- --
- Joseph Sirosh, PhD
- Independent Director
- 297.86K
- Karen K. McGinnis
- Lead Independent Director
- 172.49K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data